B
Benitec Biopharma Inc. (BNTC)
NCM – Real Time Price. Currency in USD
11.84
-0.24 (-1.99%)
At close: May 12, 2026, 4:00 PM EDT
11.84
0.00 (0.00%)
After-hours: May 12, 2026, 4:10 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
11.84
-0.24 (-1.99%)
At close: May 12, 2026, 4:00 PM EDT
11.84
0.00 (0.00%)
After-hours: May 12, 2026, 4:10 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 67.69 | 6.05 | 10 | |
| Quick ratio | 67.69 | 5.63 | 10 | |
| Debt to Equity | 0.01 | 0.30 | 10 | |
| Debt to Assets | 0.01 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 73K | 75K | N/A | N/A | N/A |
| Gross Profit | -328K | -306K | -343K | -396K | -462K |
| Operating Income | -18M | -19M | -23M | -42M | -43M |
| Net Income | -18M | -20M | -22M | -38M | -39M |
| EBITDA | -17M | -19M | -22M | -41M | -43M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -14.58 | 1.0 |
| Next quarter | N/A | 27.57 | 5.5 |
| Current year | N/A | -7.62 | 1.0 |
| Next year | N/A | 1.77 | 2.0 |
| Weighted average score | 2.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -32.03 | -18.17 | -13.39 | 3.3 |
| Y/Y | 999 | -23.91 | 21.21 | 49.69 | 7.8 |
| 3y average | 300.58 | -30.96 | 67.59 | -14.13 | 5.5 |
| 5y average | 177.26 | -38.36 | 58.77 | -27.07 | 5.5 |
| Weighted average score | 5.5 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $188.9M significantly exceed its total debt $987.0K, ensuring strong financial flexibility
Total current assets $189.6M exceed Total current liabilities $2.8M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$3.8M limits the company's ability to reinvest or pay down debt